controlled nuclear reactions. The most common method today is through nuclear fission, though other methods include nuclear fusion and radioactive decay. All utility-scale reactors heat water to produce steam, which is then converted into mechanical work for the purpose of generating electricity or propulsion. In 2007, 14% of the world's electricity came from nuclear power. More than 150 nuclear-powered naval vessels have been built, and a few radioisotope rockets have been produced. Nuclear life cycle The Nuclear Fuel Cycle begins when uranium is mined, enriched, and manufactured into nuclear fuel, which is delivered to a nuclear power plant. After usage in the power plant, the spent fuel is delivered to a reprocessing plant or to a final repository for geological disposition. In reprocessing 95% of spent fuel can be recycled to be returned to usage in a power plant. What is nuclear energy?
Soolte spasmid Pahaloomulised kasvajad Unetus Neeru- ja sapikivid Stress Närvisüsteemi probleemid Jäsemete tursed Traumade järelravi Rasvumine Tselluliit Kiirgusravi Esimene kiirgusravi tehti 1922.aastal naistekliinikus. Kiirgusravi on lokaalne ravimeetod, mida kasutatakse üksi või kombineerituna teiste ravimeetoditega. Tüübid: · Väline kiiritusravi · Brahhüteraapia · Radioisotope ravi Kõrvaltoimed: · Epiteeli pinna kahjustus · Suu ja neelu haavandid · Soole ebamugavustunne (valu, kõhulahtisus) · Paistetus (turse) · Viljatus Hilisemad kõrvaltoimed: · Fibroos koed, mis kiiritusel muutuvad vähem elastseteks · Epileerimine (juuste väljalangemine) · Kuivus (suu/silma kuivus) · Vähk · Südamehaigus Valgusravi liigid · UVB teraapia · SAD valgusravi · Punase ja sinise valgusravi
leading to apoptosis (represented by the mitochondrion). It can also be mediated by receptor antagonist activity, such as an antibody binding to a cell surface receptor and blocking dimerization, kinase activation and downstream signaling, leading to reduced proliferation and apoptosis. An antibody binding to an enzyme can lead to neutralization, signaling abrogation and cell death, and conjugated antibodies can be used to deliver a payload (such as a drug, toxin, small interfering RNA or radioisotope) to a tumor cell. b) Immune-mediated tumor cell killing can be carried out by the induction of phagocytosis, complement activation, antibody-dependent cellular cytotoxicity (ADCC), genetically modified T cells being targeted to the tumor by single-chain variable fragment (scFv), T cells being activated by antibody-mediated cross-presentation of antigen to dendritic cells, and inhibition of T cell inhibitory receptors, such as cytotoxic T lymphocyte- associated antigen 4 (CTLA4).